Current Onyx decision is whether to offer Onyx US commercial team jobs

[Anonymous]

Seems that Erin Lavelle formerly of corp dev and now in the global commercial organization is looking to be an active leader on Kyprolis. She as well as current OBU management wants a clean house of Onyx employees but wants them to first transfer their knowledge over.

 

[Anonymous]

Seems that Erin Lavelle formerly of corp dev and now in the global commercial organization is looking to be an active leader on Kyprolis. She as well as current OBU management wants a clean house of Onyx employees but wants them to first transfer their knowledge over.

Unless Amgen puts in a healthy retention bonus no transfer will happen as very few will we left.

 

[Anonymous]

Unless Amgen puts in a healthy retention bonus no transfer will happen as very few will we left.

What they mean is transfer knowledge aka how to market kyprolis aka show us how to not suck in therapeutic onc

 

[Anonymous]

What they mean is transfer knowledge aka how to market kyprolis aka show us how to not suck in therapeutic onc

No knowledge transfer needed. Onyx people are all dumb so you would be learning it the wrong way. Best to start over and get rid of onyx folks ASAP.

 

[Anonymous]

No knowledge transfer needed. Onyx people are all dumb so you would be learning it the wrong way. Best to start over and get rid of onyx folks ASAP.

Funny since we schooled you in Vectibix....you guys are supportive care hacks. Stick to that and let the adults sell therapeutics. Back to the kiddy pool OBU'ers

Oh btw unless you can't read you would know that Kyprolis will be led by an Onyx person and sold by the current Kyprolis and Nexavar team.

 

[Anonymous]

CRY CRY CRY ONYX! YOUR DAYS ARE OVER! AMGEN TIME BABY!!!!

 

[Anonymous]

CRY CRY CRY ONYX! YOUR DAYS ARE OVER! AMGEN TIME BABY!!!!

Dude we do not care. We laugh at you and your posts and we are laughing all the way to the bank!